When considering what names to put on your watch list, look for stocks with an 80 or higher RS Rating. Regeneron Pharmaceuticals stock now meets that criteria, with a jump from 80 to 85 Wednesday.
As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength.
IBD's unique rating identifies market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's price behavior over the trailing 52 weeks compares to all the other stocks in our database.
History reveals that the best stocks typically have an 80 or better RS Rating as they launch their biggest price moves.
Looking For The Best Stocks To Buy And Watch? Start Here
Is Regeneron Pharmaceuticals Stock A Buy?
Regeneron Pharmaceuticals stock is trying to complete a with an 847.50 buy point. See if it can break out in volume at least 40% higher than normal. Read "Looking For The Next Big Stock Market Winners? Start With These 3 Steps" for more tips.
In terms of top and bottom line numbers, the company has posted two quarters of increasing earnings growth. Revenue gains have also risen during the same period.
Regeneron Pharmaceuticals stock holds the No. 8 rank among its peers in the Medical-Biomed/Biotech industry group. Amphastar Pharm and HUTCHMED (China) ADR are also among the group's highest-rated stocks. For more industry news, check out "Biotech And Pharmaceutical Industry And Stock News."
